Unresolved disorder model. using A ATOM 161 N AILE 22 7.567 3.859 23.818 0.50 9.65 N Unresolved disorder model. using A ATOM 162 N BILE 22 7.555 3.855 23.838 0.50 9.90 N Unresolved disorder model. using A ATOM 163 CA AILE 22 6.318 3.747 24.572 0.50 9.24 C Unresolved disorder model. using A ATOM 164 CA BILE 22 6.310 3.735 24.597 0.50 9.22 C Unresolved disorder model. using A ATOM 165 C AILE 22 5.709 2.346 24.448 0.50 8.51 C Unresolved disorder model. using A ATOM 166 C BILE 22 5.690 2.339 24.447 0.50 8.45 C Unresolved disorder model. using A ATOM 167 O AILE 22 4.811 1.997 25.227 0.50 8.70 O Unresolved disorder model. using A ATOM 168 O BILE 22 4.765 1.980 25.187 0.50 8.39 O Unresolved disorder model. using A ATOM 169 CB AILE 22 5.332 4.836 24.116 0.50 9.43 C Unresolved disorder model. using A ATOM 170 CB BILE 22 5.298 4.806 24.178 0.50 9.27 C Unresolved disorder model. using A ATOM 171 CG1AILE 22 4.277 5.199 25.159 0.50 10.38 C Unresolved disorder model. using A ATOM 172 CG1BILE 22 4.217 5.020 25.239 0.50 10.31 C Unresolved disorder model. using A ATOM 173 CG2AILE 22 4.691 4.448 22.788 0.50 10.71 C Unresolved disorder model. using A ATOM 174 CG2BILE 22 4.647 4.513 22.835 0.50 9.08 C Unresolved disorder model. using A ATOM 175 CD1AILE 22 4.843 5.714 26.470 0.50 16.86 C Unresolved disorder model. using A ATOM 176 CD1BILE 22 3.341 6.212 24.934 0.50 9.79 C Unresolved disorder model. using A ATOM 492 N AHIS 64 -0.597 -2.307 6.285 0.70 8.88 N Unresolved disorder model. using A ATOM 493 N BHIS 64 -0.586 -2.337 6.328 0.30 9.02 N Unresolved disorder model. using A ATOM 494 CA AHIS 64 -0.693 -3.021 7.563 0.70 8.97 C Unresolved disorder model. using A ATOM 495 CA BHIS 64 -0.675 -3.115 7.568 0.30 8.39 C Unresolved disorder model. using A ATOM 496 C AHIS 64 -2.092 -3.607 7.742 0.70 8.45 C Unresolved disorder model. using A ATOM 497 C BHIS 64 -2.107 -3.605 7.805 0.30 8.51 C Unresolved disorder model. using A ATOM 498 O AHIS 64 -2.155 -4.696 8.291 0.70 16.74 O Unresolved disorder model. using A ATOM 499 O BHIS 64 -2.274 -4.617 8.470 0.30 15.04 O Unresolved disorder model. using A ATOM 500 CB AHIS 64 -0.301 -2.118 8.716 0.70 12.58 C Unresolved disorder model. using A ATOM 501 CB BHIS 64 -0.182 -2.393 8.809 0.30 8.74 C Unresolved disorder model. using A ATOM 502 CG AHIS 64 0.968 -1.346 8.546 0.70 13.74 C Unresolved disorder model. using A ATOM 503 CG BHIS 64 -0.695 -1.040 9.160 0.30 8.57 C Unresolved disorder model. using A ATOM 504 ND1AHIS 64 0.996 0.004 8.271 0.70 18.01 N Unresolved disorder model. using A ATOM 505 ND1BHIS 64 -1.728 -0.722 10.013 0.30 12.53 N Unresolved disorder model. using A ATOM 506 CD2AHIS 64 2.238 -1.810 8.626 0.70 16.75 C Unresolved disorder model. using A ATOM 507 CD2BHIS 64 -0.202 0.152 8.715 0.30 9.84 C Unresolved disorder model. using A ATOM 508 CE1AHIS 64 2.294 0.370 8.164 0.70 22.91 C Unresolved disorder model. using A ATOM 509 CE1BHIS 64 -1.890 0.578 10.094 0.30 14.49 C Unresolved disorder model. using A ATOM 510 NE2AHIS 64 3.017 -0.695 8.398 0.70 23.14 N Unresolved disorder model. using A ATOM 511 NE2BHIS 64 -0.983 1.137 9.309 0.30 14.28 N Unresolved disorder model. using A ATOM 816 N AGLN 103 -6.487 -17.648 15.706 0.50 7.74 N Unresolved disorder model. using A ATOM 817 N BGLN 103 -6.525 -17.641 15.700 0.50 7.95 N Unresolved disorder model. using A ATOM 818 CA AGLN 103 -5.734 -16.468 16.098 0.50 6.02 C Unresolved disorder model. using A ATOM 819 CA BGLN 103 -5.802 -16.448 16.123 0.50 7.43 C Unresolved disorder model. using A ATOM 820 C AGLN 103 -6.147 -15.308 15.188 0.50 5.58 C Unresolved disorder model. using A ATOM 821 C BGLN 103 -6.200 -15.301 15.191 0.50 7.62 C Unresolved disorder model. using A ATOM 822 O AGLN 103 -6.683 -15.549 14.114 0.50 9.68 O Unresolved disorder model. using A ATOM 823 O BGLN 103 -6.761 -15.501 14.124 0.50 5.51 O Unresolved disorder model. using A ATOM 824 CB AGLN 103 -4.242 -16.703 15.976 0.50 7.09 C Unresolved disorder model. using A ATOM 825 CB BGLN 103 -4.311 -16.684 16.106 0.50 8.57 C Unresolved disorder model. using A ATOM 826 CG AGLN 103 -3.760 -16.920 14.531 0.50 6.20 C Unresolved disorder model. using A ATOM 827 CG BGLN 103 -3.751 -17.171 14.753 0.50 11.84 C Unresolved disorder model. using A ATOM 828 CD AGLN 103 -2.449 -17.663 14.492 0.50 9.25 C Unresolved disorder model. using A ATOM 829 CD BGLN 103 -2.697 -18.236 15.017 0.50 22.22 C Unresolved disorder model. using A ATOM 830 OE1AGLN 103 -2.327 -18.792 15.007 0.50 9.73 O Unresolved disorder model. using A ATOM 831 OE1BGLN 103 -2.701 -19.358 14.483 0.50 30.32 O Unresolved disorder model. using A ATOM 832 NE2AGLN 103 -1.459 -17.116 13.826 0.50 6.89 N Unresolved disorder model. using A ATOM 833 NE2BGLN 103 -1.741 -17.915 15.891 0.50 13.72 N Unresolved disorder model. using A ATOM 1271 N AASP 162 -16.325 -7.474 -0.744 0.50 15.79 N Unresolved disorder model. using A ATOM 1272 N BASP 162 -16.251 -7.458 -0.846 0.50 13.72 N Unresolved disorder model. using A ATOM 1273 CA AASP 162 -16.566 -7.287 -2.167 0.50 16.23 C Unresolved disorder model. using A ATOM 1274 CA BASP 162 -16.185 -7.515 -2.314 0.50 13.45 C Unresolved disorder model. using A ATOM 1275 C AASP 162 -15.452 -6.420 -2.776 0.50 15.77 C Unresolved disorder model. using A ATOM 1276 C BASP 162 -15.480 -6.308 -2.906 0.50 14.31 C Unresolved disorder model. using A ATOM 1277 O AASP 162 -15.010 -6.744 -3.889 0.50 20.27 O Unresolved disorder model. using A ATOM 1278 O BASP 162 -15.345 -6.176 -4.126 0.50 23.50 O Unresolved disorder model. using A ATOM 1279 CB AASP 162 -17.940 -6.682 -2.445 0.50 17.33 C Unresolved disorder model. using A ATOM 1280 CB BASP 162 -17.598 -7.655 -2.832 0.50 13.37 C Unresolved disorder model. using A ATOM 1281 CG AASP 162 -19.145 -7.591 -2.284 0.50 20.33 C Unresolved disorder model. using A ATOM 1282 CG BASP 162 -18.218 -9.039 -2.703 0.50 12.80 C Unresolved disorder model. using A ATOM 1283 OD1AASP 162 -18.918 -8.815 -2.157 0.50 22.96 O Unresolved disorder model. using A ATOM 1284 OD1BASP 162 -17.551 -10.103 -2.796 0.50 17.29 O Unresolved disorder model. using A ATOM 1285 OD2AASP 162 -20.324 -7.136 -2.270 0.50 22.60 O Unresolved disorder model. using A ATOM 1286 OD2BASP 162 -19.458 -9.066 -2.529 0.50 15.26 O Unresolved disorder model. using A ATOM 1353 N ALYS 172 -3.140 1.276 -2.422 0.50 11.24 N Unresolved disorder model. using A ATOM 1354 N BLYS 172 -3.131 1.269 -2.445 0.50 11.35 N Unresolved disorder model. using A ATOM 1355 CA ALYS 172 -4.353 1.368 -3.219 0.50 11.78 C Unresolved disorder model. using A ATOM 1356 CA BLYS 172 -4.364 1.339 -3.211 0.50 11.94 C Unresolved disorder model. using A ATOM 1357 C ALYS 172 -5.560 1.746 -2.383 0.50 10.33 C Unresolved disorder model. using A ATOM 1358 C BLYS 172 -5.518 1.819 -2.346 0.50 10.82 C Unresolved disorder model. using A ATOM 1359 O ALYS 172 -5.749 1.166 -1.314 0.50 11.56 O Unresolved disorder model. using A ATOM 1360 O BLYS 172 -5.693 1.409 -1.206 0.50 8.83 O Unresolved disorder model. using A ATOM 1361 CB ALYS 172 -4.513 0.014 -3.926 0.50 12.88 C Unresolved disorder model. using A ATOM 1362 CB BLYS 172 -4.682 -0.022 -3.837 0.50 11.78 C Unresolved disorder model. using A ATOM 1363 CG ALYS 172 -3.393 -0.208 -4.952 0.50 17.16 C Unresolved disorder model. using A ATOM 1364 CG BLYS 172 -3.737 -0.491 -4.938 0.50 15.01 C Unresolved disorder model. using A ATOM 1365 CD ALYS 172 -3.914 -0.939 -6.178 0.50 19.89 C Unresolved disorder model. using A ATOM 1366 CD BLYS 172 -3.617 0.467 -6.087 0.50 18.62 C Unresolved disorder model. using A ATOM 1367 CE ALYS 172 -2.887 -0.735 -7.296 0.50 24.55 C Unresolved disorder model. using A ATOM 1368 CE BLYS 172 -3.538 -0.140 -7.463 0.50 25.45 C Unresolved disorder model. using A ATOM 1369 NZ ALYS 172 -3.234 0.308 -8.297 0.50 33.43 N Unresolved disorder model. using A ATOM 1370 NZ BLYS 172 -3.754 -1.611 -7.573 0.50 35.76 N Unresolved disorder model. using A ATOM 1700 N AGLU 214 -20.004 -9.557 23.175 0.50 6.98 N Unresolved disorder model. using A ATOM 1701 N BGLU 214 -19.962 -9.512 23.157 0.50 8.16 N Unresolved disorder model. using A ATOM 1702 CA AGLU 214 -20.559 -10.479 22.200 0.50 7.29 C Unresolved disorder model. using A ATOM 1703 CA BGLU 214 -20.564 -10.352 22.147 0.50 8.20 C Unresolved disorder model. using A ATOM 1704 C AGLU 214 -19.792 -10.347 20.883 0.50 6.60 C Unresolved disorder model. using A ATOM 1705 C BGLU 214 -19.785 -10.320 20.836 0.50 7.58 C Unresolved disorder model. using A ATOM 1706 O AGLU 214 -19.762 -9.206 20.348 0.50 6.91 O Unresolved disorder model. using A ATOM 1707 O BGLU 214 -19.703 -9.223 20.218 0.50 7.83 O Unresolved disorder model. using A ATOM 1708 CB AGLU 214 -22.052 -10.232 21.950 0.50 6.95 C Unresolved disorder model. using A ATOM 1709 CB BGLU 214 -22.011 -9.884 21.915 0.50 8.62 C Unresolved disorder model. using A ATOM 1710 CG AGLU 214 -22.676 -11.181 20.933 0.50 11.01 C Unresolved disorder model. using A ATOM 1711 CG BGLU 214 -22.815 -10.866 21.080 0.50 12.03 C Unresolved disorder model. using A ATOM 1712 CD AGLU 214 -24.185 -11.055 20.806 0.50 12.14 C Unresolved disorder model. using A ATOM 1713 CD BGLU 214 -24.229 -10.406 20.780 0.50 13.73 C Unresolved disorder model. using A ATOM 1714 OE1AGLU 214 -24.777 -10.025 21.190 0.50 9.08 O Unresolved disorder model. using A ATOM 1715 OE1BGLU 214 -24.628 -10.692 19.637 0.50 16.53 O Unresolved disorder model. using A ATOM 1716 OE2AGLU 214 -24.799 -12.030 20.303 0.50 14.43 O Unresolved disorder model. using A ATOM 1717 OE2BGLU 214 -24.904 -9.784 21.623 0.50 18.22 O Unresolved disorder model. using A ATOM 1733 N ASER 217 -20.225 -13.030 13.992 0.25 10.43 N Unresolved disorder model. using A ATOM 1734 N BSER 217 -20.244 -12.982 13.985 0.25 10.27 N Unresolved disorder model. using A ATOM 1735 N CSER 217 -20.243 -13.006 13.992 0.50 10.03 N Unresolved disorder model. using A ATOM 1736 CA ASER 217 -19.709 -14.183 13.254 0.25 10.00 C Unresolved disorder model. using A ATOM 1737 CA BSER 217 -19.860 -14.149 13.203 0.25 10.09 C Unresolved disorder model. using A ATOM 1738 CA CSER 217 -19.863 -14.144 13.172 0.50 9.91 C Unresolved disorder model. using A ATOM 1739 C ASER 217 -19.665 -13.844 11.773 0.25 10.34 C Unresolved disorder model. using A ATOM 1740 C BSER 217 -19.643 -13.750 11.755 0.25 10.76 C Unresolved disorder model. using A ATOM 1741 C CSER 217 -19.604 -13.671 11.757 0.50 10.11 C Unresolved disorder model. using A ATOM 1742 O ASER 217 -20.603 -13.263 11.218 0.25 10.08 O Unresolved disorder model. using A ATOM 1743 O BSER 217 -20.471 -13.024 11.190 0.25 11.82 O Unresolved disorder model. using A ATOM 1744 O CSER 217 -20.387 -12.854 11.243 0.50 11.32 O Unresolved disorder model. using A ATOM 1745 CB ASER 217 -20.544 -15.428 13.542 0.25 10.54 C Unresolved disorder model. using A ATOM 1746 CB BSER 217 -20.938 -15.222 13.358 0.25 12.30 C Unresolved disorder model. using A ATOM 1747 CB CSER 217 -20.946 -15.234 13.203 0.50 12.30 C Unresolved disorder model. using A ATOM 1748 OG ASER 217 -21.796 -15.361 12.876 0.25 14.56 O Unresolved disorder model. using A ATOM 1749 OG BSER 217 -20.681 -16.334 12.530 0.25 13.00 O Unresolved disorder model. using A ATOM 1750 OG CSER 217 -20.988 -15.809 14.494 0.50 14.84 O Unresolved disorder model. using A ATOM 1788 N AVAL 223 -13.577 -14.457 5.656 0.50 10.05 N Unresolved disorder model. using A ATOM 1789 N BVAL 223 -13.521 -14.416 5.679 0.50 11.09 N Unresolved disorder model. using A ATOM 1790 CA AVAL 223 -12.232 -14.344 6.217 0.50 11.62 C Unresolved disorder model. using A ATOM 1791 CA BVAL 223 -12.169 -14.216 6.217 0.50 10.82 C Unresolved disorder model. using A ATOM 1792 C AVAL 223 -11.175 -14.647 5.157 0.50 11.54 C Unresolved disorder model. using A ATOM 1793 C BVAL 223 -11.128 -14.714 5.221 0.50 11.01 C Unresolved disorder model. using A ATOM 1794 O AVAL 223 -10.162 -13.941 5.095 0.50 11.08 O Unresolved disorder model. using A ATOM 1795 O BVAL 223 -9.999 -14.206 5.192 0.50 10.03 O Unresolved disorder model. using A ATOM 1796 CB AVAL 223 -12.084 -15.242 7.464 0.50 13.95 C Unresolved disorder model. using A ATOM 1797 CB BVAL 223 -12.017 -14.815 7.638 0.50 11.19 C Unresolved disorder model. using A ATOM 1798 CG1AVAL 223 -10.683 -15.214 8.044 0.50 20.75 C Unresolved disorder model. using A ATOM 1799 CG1BVAL 223 -11.999 -16.343 7.614 0.50 10.12 C Unresolved disorder model. using A ATOM 1800 CG2AVAL 223 -13.116 -14.805 8.498 0.50 17.00 C Unresolved disorder model. using A ATOM 1801 CG2BVAL 223 -10.779 -14.248 8.325 0.50 9.52 C 1